(3S,4S)-1-tert-butoxycarbonyl-3-(tert-butyldimethylsilyl)oxy-4-hydroxypyrrolidine | 372482-16-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: (3S,4S)-1-tert-butoxycarbonyl-3-(tert-butyldimethylsilyl)oxy-4-hydroxypyrrolidine
• 英文别名: t-butyl (3S,4S)-3-(t-butyldimethylsilanyloxy)-4-hydroxypyrrolidine-1-carboxylic acid；tert-butyl (3S,4S)-3-hydroxy-4-(tert-butyldimethylsilyl)oxypyrrolidine-1-carboxylate；tert-butyl (3S,4S)-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxypyrrolidine-1-carboxylate
• CAS: 372482-16-1
• 化学式: C₁₅H₃₁NO₄Si
• 分子量: 317.501
• InChiKey: OJFSWLXDIIQXCN-RYUDHWBXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.99
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  59
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (3S,4S)-1-tert-butoxycarbonyl-3-(tert-butyldimethylsilyl)oxy-4-hydroxypyrrolidine 在 palladium on activated charcoal sodium azide 、 四丁基氟化铵 、 氢气 、 sodium hydride 、 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 46.5h， 生成 3-(tert-butoxycarbonyl-(methyl)-amino)-4-methoxy-pyrrolidine-1-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  Efficient stereospecific synthesis of (S,S)-3-methoxy-4-methylaminopyrrolidine

  摘要：

  Efficient stereospecific synthesis of (S,S)-3-methoxy-4-methylaminopyrrolidine, an important intermediate for a novel quinolone antitumor agent AG-7352 is presented. Starting from either D- Or L-tartaric acid, a stereospecific synthesis of the chiral pyrrolidine was achieved via two S(N)2 displacement reactions. From the results of this synthetic study, the absolute structure of AG-7352 was chemically determined. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(01)00302-0
• 作为产物：
  描述：

  (3S,4S)-1-benzyl-4-(tert-butyldimethylsilyloxy)pyrrolidin-3-ol 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 反应 5.0h， 生成 (3S,4S)-1-tert-butoxycarbonyl-3-(tert-butyldimethylsilyl)oxy-4-hydroxypyrrolidine
  参考文献：
  名称：

  Efficient stereospecific synthesis of (S,S)-3-methoxy-4-methylaminopyrrolidine

  摘要：

  Efficient stereospecific synthesis of (S,S)-3-methoxy-4-methylaminopyrrolidine, an important intermediate for a novel quinolone antitumor agent AG-7352 is presented. Starting from either D- Or L-tartaric acid, a stereospecific synthesis of the chiral pyrrolidine was achieved via two S(N)2 displacement reactions. From the results of this synthetic study, the absolute structure of AG-7352 was chemically determined. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(01)00302-0

文献信息

• [EN] NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION<br/>[FR] NOUVEAUX DÉRIVÉS D'AMINOPYRIDINE PRÉSENTANT UNE ACTION INHIBITRICE SÉLECTIVE DE L'AURORA A
  申请人：BANYU PHARMA CO LTD

  公开号：WO2010111057A1

  公开（公告）日：2010-09-30

  The present invention relates to a compound of Formula (I): wherein: n is 0 or 1; X is O or CH2; R1 is H or C1-2 alkyl; R2 is H or C1-3 alkyl; R3 and R4 are each independently H or C1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from R10 R5 is H or OCH3; R10 is F or Cl; or a pharmaceutically acceptable salt or ester thereof.

  本发明涉及一种化合物，其化学式为（I）：其中：n为0或1；X为O或CH2；R1为H或C1-2烷基；R2为H或C1-3烷基；R3和R4分别独立地为H或C1-2烷基，其中烷基可能被选自R10的一个到三个相同或不同的取代基取代；R5为H或OCH3；R10为F或Cl；或其药学上可接受的盐或酯。
• Enantiospecific Synthesis of (3<i>R</i>,4<i>R</i>)-1-Benzyl-4-fluoropyrrolidin-3-amine Utilizing a Burgess-Type Transformation
  作者：Daniel W. Widlicka、Alexander Gontcharov、Ruchi Mehta、Dylan J. Pedro、Robert North

  DOI：10.1021/acs.oprd.9b00245

  日期：2019.9.20

  required the asymmetric synthesis of a key 3,4-trans-substituted pyrrolidine suitable for pilot-plant scale. The initial synthetic route utilized reagents and intermediates that posed safety concerns due to their energetic potential and then required supercritical fluid chromatography to access the desired single enantiomer. Burgess-type reagents provide tremendous utility in organic synthesis but see limited

  EGFR抑制剂的生产需要不对称合成适合中试规模的关键3,4-反式取代的吡咯烷。最初的合成路线使用的试剂和中间体由于其能量潜力而引起安全隐患，然后需要超临界流体色谱法才能获得所需的单一对映异构体。伯吉斯型试剂在有机合成中具有巨大的实用性，但由于成本高且不稳定，因此在大规模使用中受到限制。然而，广泛的工艺开发导致了规模友好的工艺，其中Boc-Burgess试剂的原位形成使得能够从廉价的材料中获得手性环状氨基磺酸盐。ReactIR监测用于研究中间稳定性，并能够在多千克规模上进行处理。氨基磺酸盐转化为具有完全立体特异性的反式-3-氟-4-氨基吡咯烷1。中等结晶度提供了纯度控制点，可以排除副产物和杂质，从而无需色谱。
• NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION
  申请人：Iwama Toshiharu

  公开号：US20120015940A1

  公开（公告）日：2012-01-19

  The present invention relates to a compound of Formula (I): wherein: n is 0 or 1; X is O or CH 2 ; R 1 is H or C 1-2 alkyl; R 2 is H or C 1-3 alkyl; R 3 and R 4 are each independently H or C 1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from R 10 R 5 is H or OCH 3 ; R 10 is F or Cl; or a pharmaceutically acceptable salt or ester thereof.

  本发明涉及一种公式（I）的化合物：其中：n为0或1；X为O或CH2；R1为H或C1-2烷基；R2为H或C1-3烷基；R3和R4均独立地为H或C1-2烷基，其中烷基可以被一个到三个相同或不同的取代基R10取代；R5为H或OCH3；R10为F或Cl；或其药学上可接受的盐或酯。
• Aminopyridine derivatives having Aurora A selective inhibitory action
  申请人：Vertex Pharmaceuticals Incoporated

  公开号：US08263632B2

  公开（公告）日：2012-09-11

  The present invention relates to a compound of Formula (I): wherein: n is 0 or 1; X is 0 or CH2; R1 is H or C1-2 alkyl; R2 is H or C1-3 alkyl; R3 and R4 are each independently H or C1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from R10; R5 is H or OCH3; R10 is F or Cl; or a pharmaceutically acceptable salt or ester thereof

  本发明涉及式（I）的化合物：其中：n为0或1；X为0或CH2；R1为H或C1-2烷基；R2为H或C1-3烷基；R3和R4各自独立地为H或C1-2烷基，其中烷基可被选自R10的一到三个相同或不同的取代基取代；R5为H或OCH3；R10为F或Cl；或其药学上可接受的盐或酯。
• EP2003131
  申请人：——

  公开号：——

  公开（公告）日：——